Item 1A. Risk Factors
ITEM 1A. RISK FACTORS
Our business, future financial
condition, and results of operations are subject to a number of factors, risks and uncertainties, which are disclosed in Item 1A, entitled
“Risk Factors” in Part I of our Annual Report on Form 10-K for our fiscal year ended June 30, 2024, as well as any amendments
thereto or additions and changes thereto contained in this quarterly report on Form 10-Q for the quarter ended March 31, 2025. Additional
information regarding some of those risks and uncertainties is contained in the notes to the condensed consolidated financial statements
included elsewhere in this report and in Part I, Item 2, entitled “Management’s Discussion and Analysis of Financial Condition
and Results of Operations.” The risks and uncertainties disclosed in our Form 10-K, our quarterly reports on Form 10-Q and other
reports filed with the SEC are not necessarily all of the risks and uncertainties that may affect our business, financial condition and
results of operations in the future. There have been no material changes to the risk factors as disclosed in our Annual Report on Form
10-K for the fiscal year ended June 30, 2024, except as provided in any amendments thereto and those set forth below.
Recently proposed tariffs could have
a negative effect on our business, results of operations, financial condition, and liquidity.
Starting in the first quarter
of 2025, the United States government announced additional tariffs on goods imported into the U.S. from numerous countries and multiple
nations countered with reciprocal tariffs and other actions in response. The U.S. government stated that it is willing to negotiate with
other countries regarding the tariffs. While we manufacture our products locally, we source raw materials and purchased components through
an extensive supply chain, and the tariffs may negatively impact demand and result in an increase in some product costs. We are currently
analyzing the impacts of tariffs and actions that can be taken to moderate and/or minimize their effects.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.